Johnson & Johnson's Recall Rap Sheet
Consultants to J&J buy defective Motrin from stores. The FDA says it wasn't notified of this "phantom recall."
McNeil pulls about 6.3 million bottles of tainted Tylenol Arthritis Pain caplets made in Puerto Rico.
McNeil expands withdrawal to include Benadryl Allergy, Tylenol, Children's Tylenol Meltaway, and Rolaids.
J&J recalls 135 million bottles of meds made in Fort Washington, Pa., and closes the plant.
The FDA's Joshua Sharfstein says the U.S. may pursue criminal charges against J&J.
McNeil expands the recall from its Puerto Rico plant to include five more lots of Benadryl and Tylenol.
Yet more recalls; company submits remediation plan for McNeil plants to FDA.
Company appoints Ajit Shetty as quality-control czar, announces corporation-wide standards.
J&J pulls 100,000 boxes of 1-Day Acuvue TruEye contact lenses; days later, DePuy recalls ASR hips.
13 million packages of Rolaids softchews are recalled after customers find wood and metal particles in them.
J&J withdraws 43 million bottles of Rolaids, Tylenol, Benadryl, and Sinutab.
J&J announces 2010 earnings, puts lost sales from recalls and plant slowdowns at $900 million.
J&J units announce recalls of 70,000 potentially cracked syringes preloaded with the antipsychotic Invega.
J&J withdraws 585,000 surgical sutures due to concerns about compromised sterile packaging.
David Floyd, president of DePuy Orthopaedics, announces his resignation.
J&J's Animas unit announces recall of 384,000 insulin-pump cartridges that may leak.
FDA and McNeil announce consent decree that will give agency expanded oversight of three plants.